{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:11:06Z","timestamp":1790863866490,"version":"4.1.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/mnh.0b013e32834db45d","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T18:12:03Z","timestamp":1321035123000},"page":"46-51","source":"Crossref","is-referenced-by-count":103,"title":["Sympathetic nervous system"],"prefix":"10.1097","volume":"21","author":[{"given":"Guido","family":"Grassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Seravalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.5.1.86","article-title":"Plasma catecholamines and essential hypertension: an analytical review.","volume":"5","author":"Goldstein","year":"1983","journal-title":"Hypertension"},{"key":"R2-8-20210205","first-page":"89","article-title":"Catecholamines in peripheral venous plasma in patients on chronic haemodialysis.","volume":"55","author":"McGrath","year":"1978","journal-title":"Clin Sci Mol Med"},{"key":"R3-8-20210205","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ajh.2010.154","article-title":"Sympathetic neural activity in hypertension and related diseases.","volume":"23","author":"Grassi","year":"2010","journal-title":"Am J Hypertens"},{"key":"R4-8-20210205","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/HYPERTENSIONAHA.108.119883","article-title":"Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.","volume":"54","author":"Grassi","year":"2009","journal-title":"Hypertension"},{"key":"R5-8-20210205","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1113\/expphysiol.2009.047282","article-title":"Neurogenic hypertension.","volume":"95","author":"Paton","year":"2010","journal-title":"Exp Physiol"},{"key":"R6-8-20210205","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"},{"key":"R7-8-20210205","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1681\/ASN.2008040402","article-title":"Sympathetic activation in chronic renal failure.","volume":"20","author":"Schlaich","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R8-8-20210205","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1523-1755.2004.00552.x","article-title":"Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment.","volume":"65","author":"Neumann","year":"2004","journal-title":"Kidney Int"},{"key":"R9-8-20210205","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/ndt\/gfq175","article-title":"Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment.","volume":"25","author":"Siddiqi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R10-8-20210205","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.110.164780","article-title":"Early sympathetic activation in the initial clinical stages of chronic renal failure.","volume":"57","author":"Grassi","year":"2011","journal-title":"Hypertension"},{"key":"R11-8-20210205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease.","volume":"6","author":"Sibal","year":"2010","journal-title":"Curr Cardiol Rev"},{"key":"R12-8-20210205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/HYPERTENSIONAHA.110.163584","article-title":"Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension.","volume":"57","author":"Bruno","year":"2011","journal-title":"Hypertension"},{"key":"R14-8-20210205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/01.RES.84.4.417","article-title":"Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II.","volume":"84","author":"Liu","year":"1999","journal-title":"Circ Res"},{"key":"R15-8-20210205","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1113\/jphysiol.2005.097709","article-title":"Nitric oxide inhibition and the impact on renal nerve-mediated antinatriuresis and antidiuresis in the anaesthetized rat.","volume":"569","author":"Bagnall","year":"2005","journal-title":"J Physiol"},{"key":"R16-8-20210205","first-page":"F870","article-title":"Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.","volume":"275","author":"Broere","year":"1998","journal-title":"Am J Physiol"},{"key":"R17-8-20210205","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005344-200208000-00011","article-title":"Thromboxane A2 in vasomotor effects of phenylephrine, acetylcholine, and bradykinin in rat mesenteric bed.","volume":"40","author":"Ben Cheikh","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"R18-8-20210205","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/01.hjh.0000166843.42227.92","article-title":"Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by alpha1-adrenoceptor antagonism.","volume":"23","author":"van der Linde","year":"2005","journal-title":"J Hypertens"},{"key":"R19-8-20210205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/HYPERTENSIONAHA.109.140186","article-title":"Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications.","volume":"56","author":"Joyner","year":"2010","journal-title":"Hypertension"},{"key":"R20-8-20210205","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1152\/japplphysiol.90849.2008","article-title":"Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.","volume":"105","author":"Park","year":"2008","journal-title":"J Appl Physiol"},{"key":"R21-8-20210205","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/HJH.0b013e32831fb371","article-title":"Behaviour of regional adrenergic outflow in mild-to-moderate renal failure.","volume":"27","author":"Grassi","year":"2009","journal-title":"J Hypertens"},{"key":"R22-8-20210205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa0803085","article-title":"Modulation of blood pressure by central melanocortinergic pathways.","volume":"360","author":"Greenfield","year":"2009","journal-title":"N Engl J Med"},{"key":"R23-8-20210205","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature06858","article-title":"Genetic variation in human NPY expression affects stress response and emotion.","volume":"452","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"R24-8-20210205","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jacc.2009.05.035","article-title":"Neuropeptide Y(1) receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.","volume":"54","author":"Wang","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R25-8-20210205","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00109-006-0151-4","article-title":"Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population.","volume":"85","author":"Zhao","year":"2007","journal-title":"J Mol Med"},{"key":"R26-8-20210205","first-page":"3515","article-title":"Phosducin: a candidate gene for stress-dependent hypertension.","volume":"119","author":"Grassi","year":"2009","journal-title":"J Clin Invest"},{"key":"R27-8-20210205","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.106.628859","article-title":"Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.","volume":"115","author":"Rao","year":"2007","journal-title":"Circulation"},{"key":"R28-8-20210205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/HJH.0b013e328346d72c","article-title":"Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population.","volume":"29","author":"Grassi","year":"2011","journal-title":"J Hypertens"},{"key":"R29-8-20210205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/HYPERTENSIONAHA.111.171025","article-title":"Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men.","volume":"58","author":"Lambert","year":"2011","journal-title":"Hypertension"},{"key":"R30-8-20210205","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/00004872-200110000-00003","article-title":"Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions.","volume":"19","author":"Grassi","year":"2001","journal-title":"J Hypertens"},{"key":"R31-8-20210205","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/01.hjh.0000166831.48065.06","article-title":"Angiotensin II as the link between nitric oxide and neuroadrenergic function.","volume":"23","author":"Taddei","year":"2005","journal-title":"J Hypertens"},{"key":"R33-8-20210205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/08037051.2010.484150","article-title":"Smoking is associated with chronic sympathetic activation in hypertension.","volume":"19","author":"Hering","year":"2010","journal-title":"Blood Press"},{"key":"R34-8-20210205","doi-asserted-by":"crossref","first-page":"17271","DOI":"10.1074\/jbc.R110.113175","article-title":"Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins.","volume":"285","author":"Hall","year":"2010","journal-title":"J Biol Chem"},{"key":"R35-8-20210205","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/HJH.0b013e328337a9fd","article-title":"Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea.","volume":"28","author":"Grassi","year":"2010","journal-title":"J Hypertens"},{"key":"R36-8-20210205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/HYPERTENSIONAHA.110.155663","article-title":"Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults.","volume":"56","author":"Lambert","year":"2010","journal-title":"Hypertension"},{"key":"R37-8-20210205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/HYPERTENSIONAHA.108.121467","article-title":"Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.","volume":"53","author":"Grassi","year":"2009","journal-title":"Hypertension"},{"key":"R38-8-20210205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.109.142042","article-title":"Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart.","volume":"55","author":"Levick","year":"2010","journal-title":"Hypertension"},{"key":"R39-8-20210205","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/HYPERTENSIONAHA.111.169748","article-title":"Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension.","volume":"57","author":"Zubcevic","year":"2011","journal-title":"Hypertension"},{"key":"R40-8-20210205","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1586\/erc.10.138","article-title":"Blood pressure control in resistant hypertension: new therapeutic options.","volume":"8","author":"Grassi","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R41-8-20210205","doi-asserted-by":"crossref","first-page":"H402","DOI":"10.1152\/ajpheart.00372.2010","article-title":"Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex.","volume":"299","author":"Lohmeier","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R42-8-20210205","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.140665","article-title":"Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.","volume":"55","author":"Heusser","year":"2010","journal-title":"Hypertension"},{"key":"R43-8-20210205","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jacc.2010.03.089","article-title":"Novel baroreflex activation therapy in resistant hypertension: results of a European multicenter feasibility study.","volume":"56","author":"Scheffers","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R44-8-20210205","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.HYP.3.4.404","article-title":"Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat.","volume":"3","author":"Katholi","year":"1981","journal-title":"Hypertension"},{"key":"R45-8-20210205","first-page":"97","article-title":"Cardiovascular effects of afferent renal nerve stimulation.","volume":"9","author":"Stella","year":"1987","journal-title":"Clin Exp Hypertens A"},{"key":"R46-8-20210205","first-page":"R245","article-title":"Translational medicine: the antihypertensive effect of renal denervation.","volume":"298","author":"DiBona","year":"2010","journal-title":"Am J Physiol"},{"key":"R47-8-20210205","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"R48-8-20210205","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"2 Investigators; Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.","volume":"376","author":"Symplicity","year":"2010","journal-title":"Lancet"},{"key":"R49-8-20210205","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.","volume":"57","year":"2011","journal-title":"Hypertension"},{"key":"R50-8-20210205","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMc0904179","article-title":"Renal sympathetic-nerve ablation for uncontrolled hypertension.","volume":"361","author":"Schlaich","year":"2009","journal-title":"N Engl J Med"},{"key":"R51-8-20210205","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/HJH.0b013e328344db3a","article-title":"Renal denervation: a potential new treatment modality for polycystic ovary syndrome J H","volume":"29","author":"Schlaich","year":"2011","journal-title":"ypertens"},{"key":"R52-8-20210205","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0b013e32834db45d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T04:41:48Z","timestamp":1639629708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041552-201201000-00008"}},"subtitle":["role in hypertension and in chronic kidney disease"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e32834db45d","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}